Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

OBJECTIVE: To compare the characteristics and outcomes of patients with atrial fibrillation (AF) and aortic stenosis (AS) with patients with AF with mitral regurgitation (MR) or aortic regurgitation (AR) and patients without significant valve disease (no SVD). METHODS: Using Rivaroxaban Once-Daily,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Heart
Главные авторы: Breithardt, Günter, Baumgartner, Helmut, Berkowitz, Scott D, Hellkamp, Anne S, Piccini, Jonathan P, Lokhnygina, Yuliya, Halperin, Jonathan L, Singer, Daniel E, Hankey, Graeme J, Hacke, Werner, Becker, Richard C, Nessel, Christopher C, Mahaffey, Kenneth W, Califf, Robert M, Fox, Keith A A, Patel, Manesh R
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2016
Предметы:
Valvular Heart Disease
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941167/
https://ncbi.nlm.nih.gov/pubmed/26888572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2015-308120
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы